Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Meijers, B; Vega, A; Juillard, L; Kawanishi, H; Kirsch, AH; Maduell, F; Massy, ZA; Mitra, S; Vanholder, R; Ronco, C; Cozzolino, M; Nomenclature Standardizat Fac.
Extracorporeal Techniques in End-Stage Kidney Disease
BLOOD PURIFICAT. 2023;
Doi: 10.1159/000533258
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Kirsch Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- During the last decades, various strategies have been optimized to enhance clearance of a variable spectrum of retained molecules to ensure hemodynamic tolerance to fluid removal and improve long-term survival in patients affected by end-stage kidney disease. Treatment effects are the result of the interaction of individual patient characteristics with device characteristics and treatment prescription. Historically, the nephrology community aimed to provide adequate treatment, along with the best possible quality of life and outcomes. In this article, we analyzed blood purification techniques that have been developed with their different characteristics.
- Find related publications in this database (Keywords)
- Hemodialysis
- Ultrafiltration
- Hemofiltration
- Hemodiafiltration
- Uremic toxins
- End-stage kidney disease